23 April 2020
: Case report
Metastatic Lung Cancer Presenting as Monocular Blindness and Panhypopituitarism Secondary to a Pituitary Metastasis
Challenging differential diagnosis, Rare coexistence of disease or pathology
Kelsey H. Sheahan1EF*, Gunnar C. Huffman2EF, John C. DeWitt3E, Matthew P. Gilbert1EFDOI: 10.12659/AJCR.920948
Am J Case Rep 2020; 21:e920948
Abstract
BACKGROUND: Sellar masses are most commonly pituitary adenomas, however, about 1% of surgical resected pituitary lesions are found to be metastatic disease. It is hard to distinguish pituitary adenomas from metastatic disease. The most common primary sources for pituitary metastases are breast and lung cancer.
CASE REPORT: In this paper, we report the case of a woman who presented with right-sided vision loss who was found to have a sellar mass and panhypopituitarism. Subsequent imaging showed a large mass in her left upper lung with additional lesions in the spleen and adrenal glands. Neurosurgery performed an urgent transsphenoidal resection, with pathology confirming lung adenocarcinoma.
CONCLUSIONS: This is an unusual presentation of metastatic lung cancer, with the patient’s primary symptoms being related to her pituitary metastasis and panhypopituitarism. Pituitary metastases are most commonly asymptomatic, although they can present with visual disturbances, diabetes insipidus, or panhypopituitarism. Pituitary metastases should be on the differential for sellar masses, particularly with specific radiographic findings, visual disturbances, and/or the presence of diabetes insipidus.
Keywords: Hypopituitarism, Pituitary Diseases, Adenocarcinoma of Lung, Blindness, Pituitary Neoplasms
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946954
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945924
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946204
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948113
Most Viewed Current Articles
21 Jun 2024 : Case report
93,789
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,260
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
28,206
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,017
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030